Avelas Biosciences Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Avelas Biosciences General Information

Description

Developer of intraoperative imaging technology designed for cancer surgery and therapeutic intervention. The company's technology permits the real-time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides, enabling surgeons to avoid repeat surgeries and improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avelas Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Feb-2021 Completed Clinical Trials - Phase 3
5. Accelerator/Incubator 01-Jun-2019 Completed Clinical Trials - Phase 3
4. Later Stage VC 01-Mar-2017 Completed Clinical Trials - Phase 3
3. Later Stage VC (Series C) 18-Aug-2016 Completed Clinical Trials - Phase 3
2. Later Stage VC (Series B) 10-Sep-2014 $7.4M $15.1M Completed Clinical Trials - General
1. Early Stage VC (Series A) 06-Dec-2012 $7.65M $7.65M Completed Pre-Clinical Trials
To view Avelas Biosciences’s complete valuation and funding history, request access »

Avelas Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 7,080,540 $0.001000 8% $1.06 $1.06 1x $1.06 18.91%
To view Avelas Biosciences’s complete cap table history, request access »

Avelas Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of intraoperative imaging technology designed for cancer surgery and therapeutic intervention. The company's t
Diagnostic Equipment
San Diego, CA
11 As of 2022

San Antonio, TX
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avelas Biosciences Competitors (20)

One of Avelas Biosciences’s 20 competitors is Seno Medical, a Private Equity-Backed company based in San Antonio, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Seno Medical Private Equity-Backed San Antonio, TX
Blaze Bioscience Venture Capital-Backed Seattle, WA
Aviva Systems Biology Formerly VC-backed San Diego, CA
Actym Therapeutics Venture Capital-Backed Berkeley, CA
Kubtec Medical Imaging Corporation Stratford, CT
You’re viewing 5 of 20 competitors. Get the full list »

Avelas Biosciences Patents

Avelas Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022081438-A1 Methods of using selective delivery molecules Inactive 13-Oct-2020
WO-2019204364-A1 Compositions and methods for the selective delivery of therapeutic and imaging agents Inactive 16-Apr-2018
WO-2019204363-A2 Selective delivery of therapeutic and imaging agents Inactive 16-Apr-2018
WO-2019204363-A3 Selective delivery of therapeutic and imaging agents Inactive 16-Apr-2018
JP-2023102271-A Ratiometric fluorescence imaging method Pending 07-Apr-2017 C09K11/06
To view Avelas Biosciences’s complete patent history, request access »

Avelas Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avelas Biosciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator Minority
120 Capital Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Pharmstandard (Pharmaceuticals) Corporation Minority
phs Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Avelas Biosciences FAQs

  • When was Avelas Biosciences founded?

    Avelas Biosciences was founded in 2008.

  • Where is Avelas Biosciences headquartered?

    Avelas Biosciences is headquartered in San Diego, CA.

  • What is the size of Avelas Biosciences?

    Avelas Biosciences has 11 total employees.

  • What industry is Avelas Biosciences in?

    Avelas Biosciences’s primary industry is Diagnostic Equipment.

  • Is Avelas Biosciences a private or public company?

    Avelas Biosciences is a Private company.

  • What is Avelas Biosciences’s current revenue?

    The current revenue for Avelas Biosciences is .

  • How much funding has Avelas Biosciences raised over time?

    Avelas Biosciences has raised $37.6M.

  • Who are Avelas Biosciences’s investors?

    MedTech Innovator, 120 Capital, Alexandria Venture Investments, Pharmstandard (Pharmaceuticals), and phs Ventures are 5 of 9 investors who have invested in Avelas Biosciences.

  • Who are Avelas Biosciences’s competitors?

    Seno Medical, Blaze Bioscience, Aviva Systems Biology, Actym Therapeutics, and Kubtec Medical Imaging are some of the 20 competitors of Avelas Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process